The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
04
2020
accepted:
09
11
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
20
1
2021
Statut:
epublish
Résumé
To describe prevalence, life-time prevalence and incidence of glaucoma in Norway over a 15-year period. Data from The Norwegian Prescription Database was used to identify all prescriptions for glaucoma medication during the period 2004 to 2018. Population figures and lifespan data were obtained from The National Bureau of Statistics. Of a population of 5.3 million, a total of 75733 patients using glaucoma eye drops were identified in 2018. The national prevalence was thus 1.4%, whilst in those over 70 years of age, 8.0%. When divided into counties, the prevalence varied between 1.1 and 1.9%. Overall, the prevalence was stable in the period 2004-2018. Life time prevalence was found to be 9.4% for men and 10.2% for women. National one-year incidence proportion per 10000 was 17.0 for the total population and a peak incidence of 93.8/10000 in the 80-89 year age group was identified. Glaucoma prevalence remained stable during the period 2004-2018, while incidence decreased slightly in the elderly population.
Identifiants
pubmed: 33301476
doi: 10.1371/journal.pone.0242786
pii: PONE-D-20-09318
pmc: PMC7728208
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0242786Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Acta Ophthalmol. 2008 Nov;86(7):747-54
pubmed: 18785965
Arch Ophthalmol. 1994 Jun;112(6):821-9
pubmed: 8002842
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3309-21
pubmed: 11006219
Br J Ophthalmol. 1989 Jul;73(7):483-7
pubmed: 2788015
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Br J Ophthalmol. 1981 Jan;65(1):46-9
pubmed: 6969603
Br J Ophthalmol. 2016 Jan;100(1):86-93
pubmed: 26286821
Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1695-1702
pubmed: 29774418
Acta Ophthalmol (Copenh). 1991 Jun;69(3):273-80
pubmed: 1927307
Ophthalmology. 2001 May;108(5):882-6
pubmed: 11320017
PLoS One. 2015 Jul 16;10(7):e0132048
pubmed: 26182236
Acta Ophthalmol. 2019 May;97(3):e349-e355
pubmed: 30790460
Br J Ophthalmol. 2012 Sep;96(9):1162-7
pubmed: 22653314
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Acta Ophthalmol. 2018 Nov;96(7):e859-e864
pubmed: 30178607
Br J Ophthalmol. 2000 Oct;84(10):1159-61
pubmed: 11004103
Ophthalmology. 2013 Aug;120(8):1541-5
pubmed: 23631945
Acta Ophthalmol Scand. 2005 Dec;83(6):711-5
pubmed: 16396649
Eye (Lond). 2003 Aug;17(6):747-53
pubmed: 12928689
Am J Ophthalmol. 2007 Oct;144(4):511-9
pubmed: 17893012
Ophthalmology. 1996 Oct;103(10):1661-9
pubmed: 8874440
Eur J Ophthalmol. 1996 Jan-Mar;6(1):26-9
pubmed: 8744847
Acta Ophthalmol (Copenh). 1989 Apr;67(2):204-10
pubmed: 2786315